Original filing (PDF)20251014054649NAL0002262481001

INTEGRATIVE PEPTIDES, LLC

Name: INTEGRATIVE PEPTIDES, LLC — INTEGRATIVE PEPTIDES, LLC DEFINED BENEFIT PLAN, Form 5500 (2024)
Creator: INTEGRATIVE PEPTIDES, LLC

Form 5500-SF

FILING_RECEIVED

INTEGRATIVE PEPTIDES, LLC DEFINED BENEFIT PLAN

Defined-benefit pension plan

Active participants

Accounts w/ balance

—

Plan assets (EOY)

$664K

Net assets (EOY)

$664K

Plan health score (directional)

/ 100

Grade A

Top-tier plan health

Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.

Compliance & disclosures

100

Concentration risk

Total plan cost

Vendor stack

Participation health

Decision-maker contacts

CFO / Head of HR / Benefits Manager — verified email + LinkedIn for INTEGRATIVE PEPTIDES, LLC.

Plan sponsor

Name

INTEGRATIVE PEPTIDES, LLC

EIN

83-2015575

Address

2232 EAST MAPLE AVENUE · EL SUGUNDO, CA · 90245

Phone

(310) 808-7329

Industry

Wholesale Tradesee all

Plan administrator

Same as plan sponsor.

Plan characteristics

Plan number

001

Plan year

2024

Plan year begin

2024-01-01

Tax period

2024-12-31

Filed

2025-10-14

Pension benefit codes

1A · Pay-related DB formula

1I · Frozen plan — no new benefit accrual

3D · Pre-approved plan (master / prototype / VS)

Audit & trust (Schedule H)

Auditor

—

Trustee / custodian

—

Trustee phone

—

Small plan (5500-SF) — Schedule H data not available.

Service providers (Schedule C)

Small plans don't disclose service providers

Related plans

Similar-size Wholesale Trade plans

PARAGON ENTERPRISES INC.

PARAGON ENTERPRISES INC 401(K) PROFIT SHARING PLAN & TRUST

$665K · 22 participants

B&D PHARMA LLC

B&D PHARMA LLC CASH BALANCE PENSION PLAN

$659K · 4 participants

ABELDT GP, LLC

ABELDT GP, LLC RETIREMENT PLAN

$670K · 21 participants

H2 PHARMA LLC

H2-PHARMA LLC - 401K PLAN

$670K · 13 participants

PRIMARY CARE ALLIANCE, INC.

PRIMARY CARE ALLIANCE, INC. 401(K) PROFIT SHARING PLAN

$674K · 3 participants